VBIO

Valion Bio, Inc.

Nasdaq· CIK 0001787740

$0.8251 −0.01 (−1.77%)

Oct 27 4:00 PM ET · prev $0.8400

Market cap

$2.1M

Nano cap

1 year

−98.8%

from $70.00 · Oct 27

30 days

−69.4%

from $2.70

52-week range

$0.8251–70.00

at the low

Avg volume 20D

4.34M

Sep 30 spike 52.29M

Short interest

🔒 Subscribers only

Insider net

no open-market trades · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 16 reports · 90 days

Balance 8 bearish · 0 bullish · 8 neutral oldest → newest, height = score

Avg score

·High conf. 11/16

Strongest BEARISH Valion Bio's S-3 shelf registration (File No. 333-299355) became effective on October 20, 2026, enabling the…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

E Aug 28 Trading halt: Trading Halt: VBIO — T1 (News Pending)
X Sep 15 Short interest falls 88.7% to 38.4K
X Sep 30 Short interest jumps 128.9% to 88.0K
R Oct 8 Valion Bio filed an S-3 shelf registration statement to register up…
R Oct 16 Valion Bio filed an S-3 registration statement to register up to 3,9…
R Oct 16 Valion Bio is holding a special meeting on November 12, 2026, to see…
R Oct 21 Valion Bio's S-3 shelf registration (File No. 333-299355) became eff…
R Oct 21 The SEC declared Valion Bio's S-3 shelf registration statement (File…

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
InstitutionsMIXED

Q2 2026: 1 added (0 new), 2 trimmed or exited.
TrendDOWNTREND

66% below its 50-day average. New closing low $0.8251 on Oct 27.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
GEODE CAPITAL MANAGEMENT, LLC	NEAR_EXIT	19,374	$10.1K
UBS Group AG	DOUBLED	11,094	$5.8K
HRT FINANCIAL LP	TRIM	11,462	$5.0K
Marex Group plc	ADD	59,263	$52.5K
UBS Group AG	NEAR_EXIT	2,366	$2.1K
UBS Group AG	DOUBLED	19,659	$28.5K
CITIGROUP INC	DOUBLED	4,998	$7.2K
BANK OF AMERICA CORP /DE/	ADD	13	$19.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Recent

Sep 15, 2026

Listing

Listing Status: VBIO — Normal (was Deficient)

Valion Bio, Inc. - Common stock | Nasdaq Financial Status Indicator D → N

Sep 2, 2026

Reg SHO list

Reg SHO Threshold: VBIO exited the threshold list

VALION BIO, INC. COMMON STOCK | On list since 2026-08-05

Aug 31, 2026

Trading halt

Halt Resumed: VBIO — trading resumed after T3 (News and Resumption Times)

Halted 2026-08-28T23:50:00.000Z | Resumed 2026-08-31T13:00:00.000Z

Aug 28, 2026

Trading halt

Trading Halt: VBIO — T1 (News Pending)

Valion Bio Cmn | Market: NASDAQ | Code: T1 — News Pending

Aug 28, 2026

Trading halt

Trading Halt: VBIO — T3 (News and Resumption Times)

Valion Bio Cmn | Market: NASDAQ | Code: T3 — News and Resumption Times

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Sep 22, 2026	Zikria Dean Interim CEO	AWARD	50,000 sh
Sep 18, 2026	Wolf Lisa G COO & CFO	EXERCISE	4 sh
Sep 18, 2026	Wolf Lisa G COO & CFO	TAX W/H	$4.24
Jun 18, 2026	Wolf Lisa G Chief Financial Officer	EXERCISE	92 sh
May 18, 2026	Handley Michael K Chief Executive Officer	EXERCISE	2,206 sh
May 1, 2026	Lackey Melinda General Counsel & SVP of Legal	AWARD	45,000 sh

Earnings setup

Estimates

Period	EPS est.	Range	30D rev.	Revenue
Current Q	—	—	—	$0.00
Next Q	—	—	—	$0.00
Current FY	—	—	—	$0.00
Next FY	—	—	—	$0.00

Short side

FINRA· Oct 15, 2026

🔒 Subscribers only

shares short

Trading halts

Aug 28, 2026	Resumption Scheduled	Resumed
Aug 12, 2026	Volatility Pause	Resumed
Aug 12, 2026	Volatility Pause	Resumed
Aug 12, 2026	Volatility Pause	Resumed
Aug 12, 2026	Volatility Pause	Resumed